Additional file 8 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 8. Full-length blots of GC (also named as DBP)

Additional file 5 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 5. Volcanomap

Additional file 6 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 6. GO analysi

Additional file 2 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 2. Peptide report

Additional file 4 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 4. Heatmap

Additional file 3 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 3. Protein report

Additional file 9 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 9. Full-length blots of Akt1

Additional file 7 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 7. Canonical pathways

Additional file 1 of Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage

Additional file 1. Changes in protein expression of NK1R in the hippocampal region after ICH

Additional file 10 of Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Additional file 10. Full-length blots of ApoA1